| Not Yet Recruiting | Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB Tuberculosis, Pulmonary | Phase 2 | 2026-07-01 |
| Not Yet Recruiting | Menopausal HT for Women Living With HIV (HoT) HIV Infection, Menopause | Phase 4 | 2026-04-30 |
| Recruiting | Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa HIV-1-infection | Phase 2 | 2025-01-17 |
| Active Not Recruiting | Pausing Antiretroviral Treatment Under Structured Evaluation HIV-1-infection | Phase 1 | 2024-05-28 |
| Recruiting | Observational PIC Destination Cohort HIV-1-infection | — | 2024-03-19 |
| Withdrawn | Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpiviri HIV-1-infection | Phase 4 | 2024-01-01 |
| Completed | Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide HIV Infections | Phase 4 | 2021-07-27 |
| Completed | Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection Hepatitis C Infection, HIV Infection | Phase 2 | 2019-11-20 |
| Completed | Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD HIV-1-infection | — | 2019-10-28 |
| Completed | Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavi HIV Infections, Tuberculosis | Phase 2 | 2019-05-06 |
| Completed | Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection Hepatitis C, HIV-1-infection, Liver Diseases | Phase 4 | 2018-10-22 |
| Completed | PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) HIV-1 Infection | Phase 3 | 2017-03-14 |
| Completed | Biomarkers to Predict Time to Plasma HIV RNA Rebound HIV-1 Infection | — | 2017-02-23 |
| Completed | Early ART to Limit Infection and Establishment of Reservoir HIV-1 Infection | Phase 2 | 2017-01-24 |
| Completed | Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers HIV-1 Infection | Phase 2 | 2016-04-01 |
| Terminated | 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF HIV-1 Infection, Hepatitis C | Phase 2 | 2016-02-17 |
| Completed | Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Ther HIV-1 Infection | Phase 1 / Phase 2 | 2015-12-21 |
| Completed | Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients HIV-1 Infection | Phase 2 | 2015-12-08 |
| Completed | PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB HIV-1 Infection, Tuberculosis | Phase 2 | 2015-11-03 |
| Completed | Sitagliptin for Reducing Inflammation and Immune Activation HIV-1 Infection | Phase 2 | 2015-09-01 |
| Completed | Essentiality of INH in TB Therapy Tuberculosis | Phase 2 | 2015-06-30 |
| Completed | Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART HIV-1 Infection | Phase 2 | 2014-12-30 |
| Completed | High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) Tuberculosis | Phase 2 | 2014-08-13 |
| Completed | Modulation of Immune Activation by Aspirin HIV-1 Infection | Phase 2 | 2014-08-01 |
| Completed | Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery HIV-1 Infection | Phase 2 | 2014-07-02 |
| Completed | Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection HIV-1 Infection, Hepatitis | Phase 1 | 2014-05-30 |
| Completed | Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected HIV-1 Infection, Pf Subclinical Parasitemia | Phase 1 / Phase 2 | 2014-01-10 |
| Completed | Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) HIV-1 Infection | Phase 2 | 2014-01-01 |
| Completed | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS HIV-1 Infection | Phase 3 | 2013-10-01 |
| Terminated | Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV HIV Infection, Tuberculosis | Phase 2 | 2013-07-13 |
| Completed | FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir HIV-1 Infection | Phase 4 | 2013-04-25 |
| Completed | A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure HIV-1 Infection | Phase 4 | 2013-02-22 |
| Completed | HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women HIV-1 Infection | N/A | 2012-04-04 |
| Completed | Study of Options for Second-Line Effective Combination Therapy (SELECT) HIV-1 Infection | Phase 3 | 2012-03-13 |
| Completed | Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen HIV-1 Infection | Phase 2 | 2012-01-17 |
| Completed | Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-rela HIV-1 Infection, Kaposi's Sarcoma | Phase 3 | 2011-11-18 |
| Completed | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofib HIV-1 Infection | Phase 2 | 2011-11-01 |
| Completed | Sevelamer for Reducing Endotoxemia and Immune Activation HIV-1 Infection | Phase 2 | 2011-11-01 |
| Withdrawn | Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation HIV-1 Infection | Phase 2 | 2011-11-01 |
| Completed | REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment HIV Infection | Phase 4 | 2011-10-01 |
| Completed | Rifaximin as a Modulator of Microbial Translocation and Immune Activation HIV-1 Infection | Phase 2 | 2011-09-01 |
| Completed | High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART HIV-1 Infection | Phase 2 | 2011-09-01 |
| Completed | Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis HIV-1 Infection | Phase 3 | 2011-06-01 |
| Completed | Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women HIV-1 Infection | Phase 2 | 2011-05-01 |
| Completed | Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells HIV-1 Infection | Phase 2 | 2011-04-14 |
| Terminated | Telephone Support to Improve Adherence to Anti-HIV Medications HIV Infections | Phase 2 | 2010-10-01 |
| Completed | Durability of Adherence in Self-Management of HIV HIV Infections | N/A | 2010-01-01 |
| Completed | Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HI HIV Infections | — | 2010-01-01 |
| Completed | Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Ind HIV Infections, Tuberculosis | — | 2009-12-01 |
| Completed | Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load HIV Infections | — | 2009-09-01 |
| Completed | Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People HIV Infections | — | 2009-08-01 |
| Completed | Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters HIV Infection | — | 2009-06-01 |
| Completed | Comparative Study of Three NNRTI-Sparing HAART Regimens HIV Infection | Phase 3 | 2009-05-01 |
| Completed | Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults HIV-1 Infections | Phase 2 | 2009-04-01 |
| Completed | Chloroquine for Reducing Immune Activation in HIV- Infected Individuals HIV Infections | Phase 2 | 2009-03-01 |
| Completed | Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults HIV Infections | N/A | 2009-03-01 |
| Completed | Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With HIV-1 and Hepatitis C Co-Infection | Phase 2 | 2009-03-01 |
| Completed | Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Supp HIV Infections | N/A | 2009-01-01 |
| Completed | Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy HIV Infections | N/A | 2008-01-01 |
| Completed | HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV HIV Infections | Phase 4 | 2007-05-01 |
| Terminated | Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults HIV Infections | Phase 2 | 2007-03-01 |
| Completed | NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Tr HIV Infections | Phase 3 | 2006-11-01 |
| Completed | Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis HIV Infection, Tuberculosis | Phase 4 | 2006-08-01 |
| Completed | Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women HIV Infections | — | 2006-06-01 |
| Completed | A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175 HIV Infections | — | 2006-02-01 |
| Completed | Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudin HIV Infections | Phase 3 | 2005-09-01 |
| Completed | Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-l HIV Infections | Phase 4 | 2005-05-01 |
| Terminated | Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV HIV Infections | Phase 2 | 2005-01-01 |
| Active Not Recruiting | Consent for Use of Stored Patient Specimens for Future Testing HIV Infections | — | 2002-02-13 |
| Completed | Long-Term Data Collection From Participants in Adult AIDS Clinical Trials HIV Infections | — | 2000-01-01 |